Content Library

Interviews

C Britten Cover

NEW!

Interview with Cedrik Britten, CMO, Immatics

F Lorenz Cover

NEW!

Introducing Captain T Cell

Felix Lorenz

Whitepapers

CAR-T Whitepaper Cover

NEW!

CELL AND GENE THERAPIES:
THE CATALYST FOR NOVEL COMMERCIAL STRATEGIES

Year/Month in Review

CAR-T - Jan in Review

NEW!

2021: January in Review

Year in Review

NEW!

2020: Year in Review

Survey Results

Industry Survey

NEW!

CAR-TCR Industry Survey 2020

Poll Results Cover

NEW!

CAR-TCR Digital Week Poll Results

Survey Results

CAR-TCR Summit Survey 2020 - Results

Post-Event Reports

ASH

NEW!

2020 ASH Post-Event Report

Reading Lists

Reading List Cover

NEW!

Christmas Reading List

Post-Event Report Cover

NEW!

2020 Post-Event Report

Webinars

NEW!

Bringing It All Together – From Early Technology Evaluations to Commercial Approval

There is more than meets the eye with cell therapy manufacturing than just scalability. Listen to our discussion with LonzaZIOPHARMMSKCC and Stanford Center for Cancer Cell Therapy on the lessons learned from early technology evaluations to the commercial approval of immunotherapies.

Magazine

CAR-T Mag Cover

CAR-TCR Magazine

Presentations

CAR-TCR Workshop Cover

Key Takeaways from the 'Strategic Dive' Workshops at CAR-TCR Boston 2019

Sartouris

White Paper: Advancing Next Generation Therapeutics

By Sartorius brandsIncuCyte & intellicyt

CART0TCR-EU-presentation

How to Generate Optimal-Affinity TCRs for the Clinic?

Elisa Kieback,
CEO,
T-Knife

1

Development of First Manufacturing Process to Produce CAR-Treg Cells for Clinical Use

Pierre Heimendinger,
VP Pharmaceutical Development,
TxCell

2.1

Regenerative Medicines and Cell Therapy Products: Is the NICE Therapy Products: Is the NICE Therapy

Grace Hampson,
Senior Economist
The Office of Health Economics